Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sousa-Pinto Bernardo, Bousquet Jean, Vieira Rafael José, Schünemann Holger J, Zuberbier Torsten, Bognanni Antonio, Togias Alkis, Samolinski Boleslaw, Valiulis Arunas, Williams Sian, Bedbrook Anna, Czarlewski Wienczyslawa, Torres Maria Jose, Shamji Mohamed H, Morais-Almeida Mário, Canonica G Walter, Vecillas Leticia de Las, Dykewicz Mark S, Jacomelli Cristina, Klimek Ludger, Leemann Lucas, Lourenço Olga, Palamarchuk Yuliia, Papadopoulos Nikolaos G, Pereira Ana Margarida, Savouré Marine, Toppila-Salmi Sanna K, Ventura Maria Teresa, Yepes-Nuñez Juan José, Cruz Alvaro A, Ciprandi Giorgio, Gemicioglu Bilun, Giovannini Mattia, Gradauskiene Brigita, Jartti Tuomas, Jeseňák Miloš, Kuna Piotr, Kvedariene Violeta, Larenas-Linnemann Désirée E, Latiff Amir Ha, Mohammad Yousser, Ohta Ken, Mahesh Padukudru A, Pali-Schöll Isabella, Pfaar Oliver, Regateiro Frederico S, Roche Nicolas, Taborda-Barata Luís, Ulrik Charlotte Suppli, Rostan Marylin Valentin, Viegi Giovanni, Zhang Luo, Haahtela Tari, Cherrez-Ojeda Ivan, Carlos Ivancevich Juan, Khaltaev Nikolai, Yorgancioglu Arzu, Abdullah Baharudin, Al-Ahmad Mona, Al-Nesf Maryam Ali, Amaral Rita, Asllani Julijana, Bergmann Karl-C, Bernstein Jonathan A, Blaiss Michael S, Braido Fulvio, Camargos Paulo, Carreiro-Martins Pedro, Casale Thomas, Cecchi Lorenzo, Fiocchi Alessandro, Giuliano Antonio F M, Christoff George, Cirule Ieva, de Sousa Jaime Correia, Costa Elisio M, Del Giacco Stefano, Devillier Philippe, Dokic Dejan, Hossny Elham, Iinuma Tomohisa, Irani Carla, Ispayeva Zhanat, Julge Kaja, Kaidashev Igor, Bennoor Kazi S, Kraxner Helga, Kull Inger, Kulus Marek, Kupczyk Maciej, Kurchenko Andriy, La Grutta Stefania, Miculinic Neven, Tuyet Lan Le Thi, Makris Michael, Milenkovic Branislava, Lee Sang Min, Montefort Stephen, Moreira Andre, Mullol Joaquim, Nadif Rachel, Nakonechna Alla, Neffen Hugo E, Niedoszytko Marek, Nyembue Dieudonné, O'Hehir Robyn E, Ogulur Ismail, Okamoto Yoshitaka, Olze Heidi, Palomares Oscar, Panzner Petr, Patella Vincenzo, Pawankar Ruby, Pitsios Constantinos, Popov Todor A, Puggioni Francesca, Quirce Santiago, Ramonaité Agné, Recto Marysia, Repka-Ramirez Maria Susana, Roberts Graham, Robles-Velasco Karla, Rottem Menachem, Salapatas Marianella, Sastre Joaquin, Scichilone Nicola, Sisul Juan-Carlos, Solé Dirceu, Soto-Martinez Manuel E, Sova Milan, Tantilipikorn Pongsakorn, Todo-Bom Ana, Tsaryk Vladyslav, Tsiligianni Ioanna, Urrutia-Pereira Marilyn, Valovirta Erkka, Vasankari Tuula, Wallace Dana, Wang De Yun, Worm Margitta, Yusuf Osman M, Zidarn Mihaela, Gil-Mata Sara, Marques-Cruz Manuel, Mahboub Bassam, Ansotegui Ignacio J, Romano Antonino, Aberer Werner, Artesani Maria Cristina, Azzolini Elena, Barreto Bruno, Bartra Joan, Becker Sven, Beghe Bianca, Boner Attilio, Borowiack Ewa, Bouchard Jacques, Bourgoin-Heck Melisande, Brussino Luisa, Buhl Roland, Castillo-Vizuete José Antonio, Charpin Denis, Chavannes Niels H, Chełmińska Marta, Cheng Lei, Chkhartishvili Ekaterine, Cho Seong H, Chong-Neto Herberto Jose, Choudhury Deepa, Chu Derek K, Cingi Cemal, Compalati Enrico, Costa Raquel Albuquerque, Cunha Olga Mariana, Cvetkovski Biljana, Cardona-Dahl Victoria, D'Amato Gennaro, Davies Janet, Di Bona Danilo, Gonzalez Diaz Sandra N, Dimou Maria V, Doulaptsi Maria, Ferreira-da-Silva Renato, Gawlik Radoslaw, Calvo-Gil Mario, Goksel Ozlem, Gómez Maximiliano R, Gotua Maia, Grigoreas Christos, Grisle Ineta, Guzman Maria Antonieta, Tan Rachel House, Hyland Michael, Ierodiakonou Despo, Karavelia Aspasia, Keith Paul, Kisiel Marta, Kosak Tanja Soklic, Kosnik Mitja, Koyuncu Ilgim Vardaloglu, Kritikos Vicky, Litynska Justyna, Lombardi Carlo, Louis Gilles, Martini Matteo, Meço Cem, Mesonjesi Eris, Mihaltan Florin, Moniuszko Marcin, Naclerio Robert N, Nadeau Kari C, Neisinger Sophia, Ollert Markus, Ordak Michal, Paoletti Giovanni, Park Hae-Sim, Parmelli Elena, Perdomo-Flores Edgar Arturo, Pérez José Miguel Fuentes, Pham-Thi Nhan, Prokopakis Emmanuel, Ribeiro-Vaz Inês, Rolla Giovanni, Romantowski Jan, Rombaux Philippe, Rouadi Philip W, Rukhadze Maia, Ryan Dermot, Sadowska Ewelina, Sakurai Daiju, Salameh Laila, Sarquis Faradiba Serpa, Serrano Elie, Da Silva Jane, Soyka Michael, Specjalski Krzysztof, Tomic-Spiric Vesna, Stevanovic Katarina, Subramaniam Abirami, Teixeira Maria Do Ceu, Thomander Tuuli, Vachova Martina, van Hage Marianne, Vichyanond Pakit, Wagenmann Martin, Ko Fanny Wai San, Werminghaus Pascal, Xepapadaki Paraskevi Vicky, Xiang Yi-Kui, Yang Qintai, Yeverino Daniela Rivero, Zuberbier Jaron, Fonseca João A
Аннотация
METHODS: The ARIA 2024-2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) evidence-to-decision framework. Several sources of evidence were used to inform panel judgments and recommendations, including systematic reviews, evaluation of mHealth and pharmacovigilance data, as well as a survey of experts on costs.
RESULTS: Eleven guideline questions concerning intranasal treatments for AR were prioritized, leading to recommendations. Overall, these questions concern the choice between different classes of intranasal medications-most notably, intranasal corticosteroids (INCS), antihistamines (INAH), fixed combinations of INAH+INCS and decongestants-or between different individual medications within each class. Four questions had not been evaluated in previous ARIA guidelines, while for the other three there was a change in the strength or directionality of recommendations. Overall, recommendations point to the suggested use of INAH+INCS over INAH or INCS and INCS over INAH.
CONCLUSION: This ARIA 2024-2025 article supports patients, their caregivers, and healthcare professionals in choosing an intranasal treatment. However, decisions on AR treatment should consider the clinical variability of the disease, patients' values, and the affordability of medications.